Finally, this study focused primarily on morphological features and HER2 IHC expression, without incorporating tumor infiltrating lymphocytes (TILs) or molecular tumor characteristics, which may also serve as important prognostic indicators. The gene discussed is ERBB2; the disease is neoplasm.